Spectrum Pharmaceuticals, Inc. (SPPI) Shareholder Alert: Robbins LLP Reminds Investors of Deadline for Lead Plaintiff in Class Action Against Spectrum Pharmaceuticals, Inc.

SAN DIEGO–(BUSINESS WIRE)–Class: Robbins LLP reminds investors that a stockholder has filed a class action lawsuit on behalf of all purchasers of Spectrum Pharmaceuticals, Inc. common stock. (NASDAQ: SPPI) between December 6, 2021 and September 22, 2022 for violating the Securities Exchange Act of 1934. Spectrum is a biopharmaceutical company focused on the acquisition, development …

Spectrum Pharmaceuticals, Inc. (SPPI) Shareholder Alert: Robbins LLP Reminds Investors of Deadline for Lead Plaintiff in Class Action Against Spectrum Pharmaceuticals, Inc. Read More »